Verve Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-22. The offering totals $94.0M, of which $94.0M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Burt Adelman | Director | Cambridge, MA |
| John Evans | Director | West Haven, CT |
| Sekar Kathiresan | Director | Cambridge, MA |
| Anthony Philippakis | Director | Cambridge, MA |
| Krishna Yeshwant | Director | New York, NY |
| Andrew Ashe | Executive Officer | Cambridge, MA |
| Andrew Bellinger | Executive Officer | WATERTOWN, MA |
| Sekar Kathiresan | Executive Officer | Cambridge, MA |